The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

K Liu, M Zheng, R Lu, J Du, Q Zhao, Z Li, Y Li… - Cancer Cell …, 2020 - Springer
One of the most prominent features of tumor cells is uncontrolled cell proliferation caused by
an abnormal cell cycle, and the abnormal expression of cell cycle-related proteins gives …

[HTML][HTML] P53 mutations in colorectal cancer-molecular pathogenesis and pharmacological reactivation

XL Li, J Zhou, ZR Chen, WJ Chng - World journal of …, 2015 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most common malignancies with high prevalence and
low 5-year survival. CRC is a heterogeneous disease with a complex, genetic and …

Efficient RNA drug delivery using red blood cell extracellular vesicles

WM Usman, TC Pham, YY Kwok, LT Vu, V Ma… - Nature …, 2018 - nature.com
Most of the current methods for programmable RNA drug therapies are unsuitable for the
clinic due to low uptake efficiency and high cytotoxicity. Extracellular vesicles (EVs) could …

N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells

Y Wang, Y Li, JI Toth, MD Petroski, Z Zhang… - Nature cell …, 2014 - nature.com
Abstract N 6-methyladenosine (m6A) has been identified as the most abundant internal
modification of messenger RNA in eukaryotes. m6A modification is involved in cell fate …

[HTML][HTML] Lin28: primal regulator of growth and metabolism in stem cells

N Shyh-Chang, GQ Daley - Cell stem cell, 2013 - cell.com
In recent years, the highly conserved Lin28 RNA-binding proteins have emerged as factors
that define stemness in several tissue lineages. Lin28 proteins repress let-7 microRNAs and …

MicroRNAs in the p53 network: micromanagement of tumour suppression

H Hermeking - Nature reviews cancer, 2012 - nature.com
In recent years, microRNAs (miRNAs) have been identified as mediators of tumour
suppression and stress responses exerted by the p53 tumour suppressor. p53-regulated …

Micro RNA‐125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease

J Banzhaf‐Strathmann, E Benito, S May… - The EMBO …, 2014 - embopress.org
Sporadic Alzheimer's disease (AD) is the most prevalent form of dementia, but no clear
disease‐initiating mechanism is known. Aβ deposits and neuronal tangles composed of …

The promise of microRNA-based therapies in Alzheimer's disease: challenges and perspectives

H Walgrave, L Zhou, B De Strooper, E Salta - Molecular …, 2021 - Springer
Multi-pathway approaches for the treatment of complex polygenic disorders are emerging as
alternatives to classical monotarget therapies and microRNAs are of particular interest in …

A step-by-step microRNA guide to cancer development and metastasis

GS Markopoulos, E Roupakia, M Tokamani… - Cellular Oncology, 2017 - Springer
Background Cancer is one of the leading causes of mortality. The neoplastic transformation
of normal cells to cancer cells is caused by a progressive accumulation of genetic and …

Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy

M Prokocimer, A Molchadsky… - Blood, The Journal of the …, 2017 - ashpublications.org
The heterogeneous nature of acute myeloid leukemia (AML) and its poor prognosis
necessitate therapeutic improvement. Current advances in AML research yield important …